✦ LIBER ✦

Melatonin and tryptophan circadian profiles in patients with advanced non-small cell lung cancer

✍ Scribed by Shilian Hu; Gan Shen; Shi Yin; Weiping Xu; Bing Hu

Book ID: 107648615
Publisher: Springer Healthcare Communications
Year: 2009
Tongue: English
Weight: 156 KB
Volume: 26
Category: Article
ISSN: 0741-238X
DOI: 10.1007/s12325-009-0068-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Supportive care in patients with advance

Supportive care in patients with advanced non-small-cell lung cancer

✍ Di Maio, M; Perrone, F; Gallo, C; Iaffaioli, R V; Manzione, L; Piantedosi, F V; 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 133 KB

Non-surgical therapy for patients with a

Non-surgical therapy for patients with advanced non-small cell lung cancer

✍ ML LIAO 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 707 KB

Non-surgical therapy for patients with a

Non-surgical therapy for patients with advanced non-small cell lung cancer

✍ Stephen J CLARKE; Michael J BOYER 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 735 KB

Gefitinib in advanced non-small cell lun

Gefitinib in advanced non-small cell lung cancer

✍ R. Sharma; M. Boyer; S. Clarke; M. Millward 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 417 KB

Gemcitabine pharmacokinetics and interac

Gemcitabine pharmacokinetics and interaction with paclitaxel in patients with advanced non-small-cell lung cancer

✍ Stacy S. Shord; Stephanie R. Faucette; Heidi H. Gillenwater; Scott L. Pescatore; 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 275 KB

Simultaneous chemoradiation in advanced

Simultaneous chemoradiation in advanced non-small cell lung cancer

✍ Julianna Pisch; Stephen Malamud; James Harvey; Edward J. Beattie 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 558 KB

We designed our study to evaluate the safety and efficacy of simultaneous chemoradiation therapy in an accelerated, twice-a-day schedule to improve local control and survival in advanced lung cancer patients. Forty-one patients were entered into the study. Twenty-three had stage IIIB and 18 had stag